Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Sarcoma 1Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 19Carcinoma, Hepatocellular 18Pancreatic Neoplasms 14Colorectal Neoplasms 12Esophageal Neoplasms 9Neoplasm Metastasis 8Esophageal Squamous Cell Carcinoma 7Biliary Tract Neoplasms 7Lung Neoplasms 6Liver Neoplasms 6Cholangiocarcinoma 6Breast Neoplasms 6Neoplasms 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Melanoma 3Sarcoma 2Rectal Neoplasms 2Advanced Pancreatic Cancer 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Esophageal Squamous Cell Carcinoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Cancer Metastatic 1Ovarian Neoplasms 1Oligometastatic Gastrointestinal Cancer 1

Interventions

pembrolizumab 11Gemcitabine 11Oxaliplatin 7Nivolumab 7Irinotecan 7Fluorouracil 7Capecitabine 7durvalumab 6Sorafenib 6Leucovorin 6Cyclophosphamide 6Paclitaxel 5Ipilimumab 5Cisplatin 4tislelizumab 3poly ICLC 3lenvatinib 3fludarabine 3Sunitinib 3Radiotherapy 3Cetuximab 3130-nm albumin-bound paclitaxel 3seocalcitol 2selinexor 2pemigatinib 2futuximab 2fludarabine phosphate 2donafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Injections × Gastrointestinal × Clear all
NCT03985072 2022-02-24

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

Andes Biotechnologies

Phase 1 Completed
67 enrolled
GastrointestinalGynecologic

Carcinoma, Uterine Cervical Neoplasms, Gallbladder Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡